BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16435043)

  • 1. Retrospective and prospective evaluation of the Amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples.
    Poljak M; Fujs K; Seme K; Kocjan BJ; Vrtacnik-Bokal E
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Dec; 14(4):147-52. PubMed ID: 16435043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
    J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance.
    Halfon P; Trepo E; Antoniotti G; Bernot C; Cart-Lamy P; Khiri H; Thibaud D; Marron J; Martineau A; Pénaranda G; Benmoura D; Blanc B;
    J Clin Microbiol; 2007 Feb; 45(2):313-6. PubMed ID: 17122007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
    Sandri MT; Lentati P; Benini E; Dell'Orto P; Zorzino L; Carozzi FM; Maisonneuve P; Passerini R; Salvatici M; Casadio C; Boveri S; Sideri M
    J Clin Microbiol; 2006 Jun; 44(6):2141-6. PubMed ID: 16757611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.
    Seme K; Fujs K; Kocjan BJ; Poljak M
    J Virol Methods; 2006 Jun; 134(1-2):252-6. PubMed ID: 16417931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.
    Stevens MP; Garland SM; Rudland E; Tan J; Quinn MA; Tabrizi SN
    J Clin Microbiol; 2007 Jul; 45(7):2130-7. PubMed ID: 17494721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hybrid capture 2 HPV DNA test and two variants of polymerase chain reaction (PCR-PGMY11/ PGMY09 and PCR-CPI/CPIIG) according to HPV types.
    Salimović-Besic I
    Med Arh; 2007; 61(3):135-7. PubMed ID: 18232273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.
    Poljak M; Oštrbenk A
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):43-7. PubMed ID: 23836358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of accuracy of three assays for human papillomavirus detection and typing: Hybrid Capture 2, HPV Consensus kit and Amplicor HPV].
    Hantz S; Caly H; Decroisette E; Dutrop A; Bakeland D; Pascal B; Darreye G; Dussartre C; Renaudie J; Rogez S; Aubard Y; Denis F; Alain S
    Pathol Biol (Paris); 2008 Feb; 56(1):29-35. PubMed ID: 18178026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
    Harnish DG; Belland LM; Scheid EE; Rohan TE
    Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluorescence in situ hybridization, hybrid capture 2 and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens.
    Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
    Anal Quant Cytol Histol; 2009 Aug; 31(4):208-16. PubMed ID: 19736868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test.
    Schopp B; Holz B; Zago M; Stubenrauch F; Petry KU; Kjaer SK; Iftner T
    J Med Virol; 2010 Apr; 82(4):605-15. PubMed ID: 20166179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
    Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M
    J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
    Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
    J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV Direct Flow CHIP: a new human papillomavirus genotyping method based on direct PCR from crude-cell extracts.
    Herraez-Hernandez E; Alvarez-Perez M; Navarro-Bustos G; Esquivias J; Alonso S; Aneiros-Fernandez J; Lacruz-Pelea C; Sanchez-Aguera M; Santamaria JS; de Antonio JC; Rodriguez-Peralto JL
    J Virol Methods; 2013 Oct; 193(1):9-17. PubMed ID: 23680093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.